Latest Fistula Stories
EXTON, Pa., Aug. 24 /PRNewswire/ -- BioTrends Research Group, Inc. recently published its TreatmentTrendsÂ®: Vascular Access report.
MALABO, Equatorial Guinea, June 18 /PRNewswire-USNewswire/ -- The Republic of Equatorial Guinea (Republica de Guinea Ecuatorial, along with the United Nations Population Fund (UNFPA), is working to strengthen and equip health facilities throughout the country to boost access to reproductive health services.
SANTA CLARA, Calif. and CHICAGO, June 2 /PRNewswire/ -- ATHENA International awarded Dr. Mulu Muleta, Senior Medical Advisor to Women and Health Alliance International, Ethiopia, the 2010 Global ATHENA Leadership Award at the 16(th) annual ATHENA Women's Leadership Summit in Chicago.
Duodenocaval fistula (DCF) is an uncommon but lethal clinical entity.
Mechanical bowel preparations (MBP) are commonly administered preoperatively to patients who undergo a pancreaticoduodenectomy (PD) (Whipple procedure) to treat benign and malignant tumors of the pancreas, common bile duct or duodenum.
Gastrointestinal (GI) chronic perforations require closure and control of extraluminal collections and sepsis.
Long-term complications after procedures to close coronary artery fistulas are particularly prevalent among those whose abnormal connections to the heart result in drainage into the coronary sinus.
ATLANTA, March 8 /PRNewswire/ -- In honor of the 100th anniversary of International Women's Day, Health & Development International (HDI) announced the results of its Rapid Maternal Mortality and Obstetric Fistula Prevention Project today, in advance of its second hosted global meeting on this topic to be held at The Carter Center in Atlanta on March 9 and 10. This is the world's first pilot project devoted to the rapid prevention of obstetric fistula in women.
WALTHAM, Mass., Nov. 23 /PRNewswire/ -- Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation.
MADRID, November 11 /PRNewswire/ -- Cellerix, a product-focused biopharmaceutical company which develops innovative medicines based on cell therapy, today announced the successful first closing of its financing round, raising EUR27 million.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.